ProAssurance Reports Results for First Quarter 2024
First Quarter 2024(2)
-
Gross premiums written:
$311 million (-1%) -
New business written:
$20 million (+7%) - Strong renewal pricing increases in medical professional liability business (+8%)
- Consolidated current accident year loss ratio of 79.9% (3 point improvement)
-
Consolidated combined ratio of 111.6% (2 point improvement)
-
Net investment income of
$34 million (+12%) - Consolidated operating ratio of 97.7%, (4 point improvement)
-
Book value per share of
$21.82 as ofMarch 31, 2024
|
(1) |
Represents a Non-GAAP financial measure. See a reconciliation to its GAAP counterpart under the heading “Non-GAAP Financial Measures” that follows. |
|
|
(2) |
Comparisons are to the first quarter of 2023 unless otherwise noted |
Management Commentary & Results of Operations
“Operating earnings this quarter reflected improved results in our Specialty P&C segment and a 12 percent increase in investment income. We are encouraged by the sequential improvement in the current accident year loss ratio across all operating segments. We continue to focus on disciplined underwriting, gaining rate where appropriate and managing claims in a loss environment that continues to be challenging. We are also retaining existing insureds and selectively adding new business at pricing levels that, while reflecting market realities, also helps us make progress toward our sustained profitability goals. We continue to forgo renewal and new business opportunities that we believe do not meet our expectation of rate adequacy in the current loss environment,” said
Our consolidated combined ratio also improved 2.3 points year over year, reflecting the better current accident year loss ratio. In last year’s first quarter, the combined ratio included the impact of unfavorable prior accident year development partially offset by one-time or infrequent beneficial items affecting our Specialty P&C segment’s expense ratio. Our pricing and underwriting discipline in the face of both challenging market conditions and an adverse legal environment has positioned us to build on the progress we saw in underwriting results this quarter.
Book value per share at quarter end was
|
CONSOLIDATED INCOME STATEMENT HIGHLIGHTS |
|||||||||||
|
Selected consolidated financial data for each period is summarized in the table below. |
|||||||||||
|
|
Three Months Ended |
||||||||||
|
($ in thousands, except per share data) |
2024 |
|
2023 |
|
Change |
||||||
|
Revenues |
|
|
|
|
|
||||||
|
Gross premiums written(1) |
$ |
311,341 |
|
|
$ |
315,794 |
|
|
|
(1.4 |
%) |
|
Net premiums written |
$ |
282,673 |
|
|
$ |
284,909 |
|
|
|
(0.8 |
%) |
|
Net premiums earned |
$ |
244,150 |
|
|
$ |
239,787 |
|
|
|
1.8 |
% |
|
Net investment income |
|
33,897 |
|
|
|
30,310 |
|
|
|
11.8 |
% |
|
Equity in earnings (loss) of unconsolidated subsidiaries |
|
2,963 |
|
|
|
(1,121 |
) |
|
|
364.3 |
% |
|
Net investment gains (losses)(2) |
|
(268 |
) |
|
|
2,912 |
|
|
|
(109.2 |
%) |
|
Other income (loss)(1) |
|
3,955 |
|
|
|
787 |
|
|
|
402.5 |
% |
|
Total revenues(1) |
|
284,697 |
|
|
|
272,675 |
|
|
|
4.4 |
% |
|
Expenses |
|
|
|
|
|
||||||
|
Net losses and loss adjustment expenses |
|
194,694 |
|
|
|
205,296 |
|
|
|
(5.2 |
%) |
|
Underwriting, policy acquisition and operating expenses(1) |
|
78,005 |
|
|
|
67,788 |
|
|
|
15.1 |
% |
|
SPC |
|
416 |
|
|
|
532 |
|
|
|
(21.8 |
%) |
|
SPC dividend expense (income) |
|
607 |
|
|
|
1,942 |
|
|
|
(68.7 |
%) |
|
Interest expense |
|
5,657 |
|
|
|
5,463 |
|
|
|
3.6 |
% |
|
Total expenses(1) |
|
279,379 |
|
|
|
281,021 |
|
|
|
(0.6 |
%) |
|
Income (loss) before income taxes |
|
5,318 |
|
|
|
(8,346 |
) |
|
|
163.7 |
% |
|
Income tax expense (benefit) |
|
692 |
|
|
|
(2,172 |
) |
|
|
131.9 |
% |
|
Net income (loss) |
$ |
4,626 |
|
|
$ |
(6,174 |
) |
|
|
174.9 |
% |
|
Non-GAAP operating income (loss) |
$ |
4,177 |
|
|
$ |
(7,418 |
) |
|
|
156.3 |
% |
|
Weighted average number of common shares outstanding |
|
|
|
|
|
||||||
|
Basic |
|
51,013 |
|
|
|
53,987 |
|
|
|
||
|
Diluted |
|
51,149 |
|
|
|
54,117 |
|
|
|
||
|
Earnings (loss) per share |
|
|
|
|
|
||||||
|
Net income (loss) per diluted share |
$ |
0.09 |
|
|
$ |
(0.11 |
) |
|
$ |
0.20 |
|
|
Non-GAAP operating income (loss) per diluted share |
$ |
0.08 |
|
|
$ |
(0.14 |
) |
|
$ |
0.22 |
|
|
(1) |
Consolidated totals include inter-segment eliminations. The eliminations affect individual line items only and have no effect on net income (loss). See Note 12 of the Notes to Condensed Consolidated Financial Statements in our |
|
(2) |
This line item typically includes both realized and unrealized investment gains and losses, investment impairments losses, and the change in the fair value of the contingent consideration in relation to the NORCAL acquisition. Detailed information regarding the components of net investment gains (losses) are included in Note 3 of the Notes to Condensed Consolidated Financial Statements in our |
|
The abbreviation “nm” indicates that the information or the percentage change is not meaningful. |
|
|
BALANCE SHEET HIGHLIGHTS |
|||||||
|
($ in thousands, except per share data) |
|
|
|
||||
|
Total investments |
$ |
4,333,542 |
|
|
$ |
4,349,781 |
|
|
Total assets |
$ |
5,650,036 |
|
|
$ |
5,631,925 |
|
|
Total liabilities |
$ |
4,536,971 |
|
|
$ |
4,519,945 |
|
|
Common shares (par value |
$ |
636 |
|
|
$ |
636 |
|
|
Retained earnings |
$ |
1,386,607 |
|
|
$ |
1,381,981 |
|
|
|
$ |
(469,702 |
) |
|
$ |
(469,702 |
) |
|
Shareholders’ equity |
$ |
1,113,065 |
|
|
$ |
1,111,980 |
|
|
Book value per share |
$ |
21.82 |
|
|
$ |
21.82 |
|
|
Non-GAAP adjusted book value per share(1) |
$ |
25.88 |
|
|
$ |
25.83 |
|
|
(1) |
Adjusted book value per share is a Non-GAAP financial measure. See a reconciliation of book value per share to Non-GAAP adjusted book value per share under the heading “Non-GAAP Financial Measures” that follows. |
| CONSOLIDATED KEY RATIOS | |||||
|
|
Three Months Ended |
||||
|
|
2024 |
|
2023 |
||
|
Current accident year net loss ratio |
79.9 |
% |
|
82.7 |
% |
|
Effect of prior accident years’ reserve development |
(0.2 |
%) |
|
2.9 |
% |
|
Net loss ratio |
79.7 |
% |
|
85.6 |
% |
|
Underwriting expense ratio |
31.9 |
% |
|
28.3 |
% |
|
Combined ratio |
111.6 |
% |
|
113.9 |
% |
|
Operating ratio |
97.7 |
% |
|
101.3 |
% |
|
Return on equity(1) |
1.7 |
% |
|
(2.5 |
%) |
|
Non-GAAP operating return on equity(1)(2) |
1.5 |
% |
|
(2.6 |
%) |
|
(1) |
Quarterly amounts are annualized. Refer to our |
|
(2) |
See a reconciliation of ROE to Non-GAAP operating ROE under the heading “Non-GAAP Financial Measures” that follows. |
We operate in four segments: Specialty P&C,
SPECIALTY P&C SEGMENT RESULTS
|
|
Three Months Ended |
|||||||||
|
($ in thousands) |
2024 |
|
2023 |
|
% Change |
|||||
|
Gross premiums written |
$ |
238,718 |
|
|
$ |
242,363 |
|
|
(1.5 |
%) |
|
Net premiums written |
$ |
218,699 |
|
|
$ |
217,390 |
|
|
0.6 |
% |
|
Net premiums earned |
$ |
188,888 |
|
|
$ |
183,684 |
|
|
2.8 |
% |
|
Other income |
|
1,353 |
|
|
|
990 |
|
|
36.7 |
% |
|
Total revenues |
|
190,241 |
|
|
|
184,674 |
|
|
3.0 |
% |
|
Net losses and loss adjustment expenses |
|
(152,994 |
) |
|
|
(166,029 |
) |
|
(7.9 |
%) |
|
Underwriting, policy acquisition and operating expenses |
|
(51,049 |
) |
|
|
(42,681 |
) |
|
19.6 |
% |
|
Total expenses |
|
(204,043 |
) |
|
|
(208,710 |
) |
|
(2.2 |
%) |
|
Segment results |
$ |
(13,802 |
) |
|
$ |
(24,036 |
) |
|
42.6 |
% |
|
SPECIALTY P&C SEGMENT KEY RATIOS |
|||||
|
|
Three Months Ended |
||||
|
|
2024 |
|
2023 |
||
|
Current accident year net loss ratio |
81.7 |
% |
|
86.4 |
% |
|
Effect of prior accident years’ reserve development |
(0.7 |
%) |
|
4.0 |
% |
|
Net loss ratio |
81.0 |
% |
|
90.4 |
% |
|
Underwriting expense ratio |
27.0 |
% |
|
23.2 |
% |
|
Combined ratio |
108.0 |
% |
|
113.6 |
% |
The results for the Specialty P&C segment improved over first quarter 2023, primarily reflecting our cautious underwriting and pricing decisions and our ability to target segments within healthcare where there are opportunities to write business profitably. However, competitive market conditions and the challenging loss environment in our MPL line of business continued unabated.
Our ability to write new business at better pricing than the business it replaces, coupled with strong renewal pricing and retention, continues to underscore our position of leadership in a very competitive market. We achieved renewal pricing increases of 7% and new business of
The current accident year net loss ratio improved 4.7 points, primarily due to the underwriting actions taken and pricing we have achieved over the course of the past year. We recognized net favorable prior accident year reserve development of
The first quarter 2024 expense ratio was 3.8 points above the prior year first quarter. This was largely due to a
|
WORKERS’ COMPENSATION INSURANCE SEGMENT RESULTS |
||||||||||
|
|
Three Months Ended |
|||||||||
|
($ in thousands) |
2024 |
|
2023 |
|
% Change |
|||||
|
Gross premiums written |
$ |
72,615 |
|
|
$ |
73,431 |
|
|
(1.1 |
%) |
|
Net premiums written |
$ |
50,353 |
|
|
$ |
47,572 |
|
|
5.8 |
% |
|
Net premiums earned |
$ |
41,094 |
|
|
$ |
40,803 |
|
|
0.7 |
% |
|
Other income |
|
477 |
|
|
|
581 |
|
|
(17.9 |
%) |
|
Total revenues |
|
41,571 |
|
|
|
41,384 |
|
|
0.5 |
% |
|
Net losses and loss adjustment expenses |
|
(31,636 |
) |
|
|
(30,844 |
) |
|
2.6 |
% |
|
Underwriting, policy acquisition and operating expenses |
|
(14,490 |
) |
|
|
(12,980 |
) |
|
11.6 |
% |
|
Total expenses |
|
(46,126 |
) |
|
|
(43,824 |
) |
|
5.3 |
% |
|
Segment results |
$ |
(4,555 |
) |
|
$ |
(2,440 |
) |
|
(86.7 |
%) |
|
WORKERS’ COMPENSATION INSURANCE SEGMENT KEY RATIOS |
|||
|
|
Three Months Ended |
||
|
|
2024 |
|
2023 |
|
Current accident year net loss ratio |
77.0% |
|
72.6% |
|
Effect of prior accident years’ reserve development |
0.0% |
|
3.0% |
|
Net loss ratio |
77.0% |
|
75.6% |
|
Underwriting expense ratio |
35.3% |
|
31.8% |
|
Combined ratio |
112.3% |
|
107.4% |
The Workers’
Gross premiums in our traditional business increased 7% in the first quarter compared to the same period of 2023, despite a slight reduction in policy count. The increase was primarily due to higher reported insured payrolls at renewal, positive mid-term policy endorsements, selective new business writings and the renewal of certain policies from a captive program as traditional business that were previously written in our Segregated Portfolio Cell Reinsurance segment. New business was
The current accident year net loss ratio for the first quarter of 2024 increased to 77.0%, from 72.6% as of
There was no change in prior accident year reserve estimates in the first quarter of 2024, compared to
The underwriting expense ratio for the first quarter of 2024 was 3.5 points higher than the prior year quarter, reflecting an increase in compensation-related costs, as well as decreases in audit premium, ceding commissions received from SPCs, and ULAE allocated to net losses and loss adjustment expenses.
|
SEGREGATED PORTFOLIO CELL REINSURANCE SEGMENT RESULTS |
||||||||||
|
|
Three Months Ended |
|||||||||
|
($ in thousands) |
2024 |
|
2023 |
|
% Change |
|||||
|
Gross premiums written |
$ |
15,934 |
|
|
$ |
22,881 |
|
|
(30.4 |
%) |
|
Net premiums written |
$ |
13,621 |
|
|
$ |
19,947 |
|
|
(31.7 |
%) |
|
Net premiums earned |
$ |
14,168 |
|
|
$ |
15,300 |
|
|
(7.4 |
%) |
|
Net investment income |
|
693 |
|
|
|
420 |
|
|
65.0 |
% |
|
Net investment gains (losses) |
|
1,471 |
|
|
|
1,160 |
|
|
26.8 |
% |
|
Other income (expense) |
|
(1 |
) |
|
|
1 |
|
|
(200.0 |
%) |
|
Net losses and loss adjustment expenses |
|
(10,064 |
) |
|
|
(8,423 |
) |
|
19.5 |
% |
|
Underwriting, policy acquisition and operating expenses |
|
(4,713 |
) |
|
|
(5,035 |
) |
|
(6.4 |
%) |
|
SPC |
|
(416 |
) |
|
|
(532 |
) |
|
(21.8 |
%) |
|
SPC net results |
|
1,138 |
|
|
|
2,891 |
|
|
(60.6 |
%) |
|
SPC dividend (expense) income (2) |
|
(607 |
) |
|
|
(1,942 |
) |
|
(68.7 |
%) |
|
Segment results (3) |
$ |
531 |
|
|
$ |
949 |
|
|
(44.0 |
%) |
|
(1) |
Represents the provision for |
|
(2) |
Represents the net (profit) loss attributable to external cell participants. |
|
(3) |
Represents our share of the net profit (loss) and OCI of the SPCs in which we participate. |
| SEGREGATED PORTFOLIO CELL REINSURANCE SEGMENT KEY RATIOS | |||||
|
|
Three Months Ended |
||||
|
|
2024 |
|
2023 |
||
|
Current accident year net loss ratio |
65.1 |
% |
|
64.9 |
% |
|
Effect of prior accident years’ reserve development |
5.9 |
% |
|
(9.8 |
%) |
|
Net loss ratio |
71.0 |
% |
|
55.1 |
% |
|
Underwriting expense ratio |
33.3 |
% |
|
32.9 |
% |
|
Combined ratio |
104.3 |
% |
|
88.0 |
% |
Premiums in our Segregated Portfolio Cell Reinsurance segment are primarily comprised of workers' compensation coverages assumed from our
Gross premiums written decreased in the first quarter compared to the same period in 2023, primarily due to the non-renewal of two Segregated Portfolio Cell (SPC) programs effective
Renewal premium reflected rate decreases of 1.7% and renewal retention of 76.4% in the quarter. Audit premium increased to
The current accident year net loss ratio was essentially unchanged quarter-over-quarter.
We recognized
CORPORATE SEGMENT
|
|
Three Months Ended |
|||||||||
|
($ in thousands) |
2024 |
|
2023 |
|
% Change |
|||||
|
Net investment income |
$ |
33,204 |
|
|
$ |
29,890 |
|
|
11.1 |
% |
|
Equity in earnings (loss) of unconsolidated subsidiaries: |
|
|
|
|
|
|||||
|
All other investments, primarily investment fund LPs/LLCs |
|
3,066 |
|
|
|
(767 |
) |
|
499.7 |
% |
|
Tax credit partnerships |
|
(103 |
) |
|
|
(354 |
) |
|
(70.9 |
%) |
|
Total equity in earnings (loss) of unconsolidated subsidiaries: |
|
2,963 |
|
|
|
(1,121 |
) |
|
364.3 |
% |
|
Net investment gains (losses) |
|
(1,739 |
) |
|
|
752 |
|
|
(331.3 |
%) |
|
Other income (expense) |
|
3,061 |
|
|
|
327 |
|
|
836.1 |
% |
|
Operating expenses |
|
(8,688 |
) |
|
|
(8,204 |
) |
|
5.9 |
% |
|
Interest expense |
|
(5,657 |
) |
|
|
(5,463 |
) |
|
3.6 |
% |
|
Income tax (expense) benefit |
|
(692 |
) |
|
|
2,172 |
|
|
131.9 |
% |
|
Segment results |
$ |
22,452 |
|
|
$ |
18,353 |
|
|
22.3 |
% |
|
Consolidated effective tax rate |
13.0% |
|
26.0% |
|
|
|||||
The current interest rate environment continues to benefit our net investment income, which increased to
Equity in earnings from our investment in LPs/LLCs, which are typically reported to us on a one-quarter lag, reflected a
The corporate segment results include
The increase in other income was driven by the effect of foreign currency exchange rate gains of
Operating expenses increased by
NON-GAAP FINANCIAL MEASURES
Non-GAAP Operating Income (Loss)
Non-GAAP operating income (loss) is a financial measure that is widely used to evaluate performance within the insurance sector. In calculating Non-GAAP operating income (loss), we have excluded the effects of the items listed in the following table that do not reflect normal results. We believe Non-GAAP operating income (loss) presents a useful view of the performance of our insurance operations; however, it should be considered in conjunction with net income (loss) computed in accordance with GAAP. The following table reconciles net income (loss) to Non-GAAP operating income (loss):
|
RECONCILIATION OF NET INCOME (LOSS) TO NON-GAAP OPERATING INCOME (LOSS) |
|||||||
|
|
Three Months Ended |
||||||
|
($ in thousands, except per share data) |
2024 |
|
2023 |
||||
|
Net income (loss) |
$ |
4,626 |
|
|
$ |
(6,174 |
) |
|
Items excluded in the calculation of Non-GAAP operating income (loss): |
|
|
|
||||
|
Net investment (gains) losses (1) |
|
268 |
|
|
|
(2,912 |
) |
|
Net investment gains (losses) attributable to SPCs which no profit/loss is retained (2) |
|
1,151 |
|
|
|
913 |
|
|
Foreign currency exchange rate (gains) losses(3) |
|
(1,929 |
) |
|
|
827 |
|
|
Guaranty fund assessments (recoupments) |
|
87 |
|
|
|
(74 |
) |
|
Pre-tax effect of exclusions |
|
(423 |
) |
|
|
(1,246 |
) |
|
Tax effect, at 21% (4) |
|
(26 |
) |
|
|
2 |
|
|
After-tax effect of exclusions |
|
(449 |
) |
|
|
(1,244 |
) |
|
Non-GAAP operating income (loss) |
$ |
4,177 |
|
|
$ |
(7,418 |
) |
|
Per diluted common share: |
|
|
|
||||
|
Net income (loss) |
$ |
0.09 |
|
|
$ |
(0.11 |
) |
|
Effect of exclusions |
|
(0.01 |
) |
|
|
(0.03 |
) |
|
Non-GAAP operating income (loss) per diluted common share |
$ |
0.08 |
|
|
$ |
(0.14 |
) |
|
(1) |
Net investment gains (losses) for the three months ended |
|
(2) |
Net investment gains (losses) on investments related to SPCs are recognized in our Segregated Portfolio Cell Reinsurance segment. SPC results, including any net investment gain or loss, that are attributable to external cell participants are reflected in the SPC dividend expense (income). To be consistent with our exclusion of net investment gains (losses) recognized in earnings, we are excluding the portion of net investment gains (losses) that is included in the SPC dividend expense (income) which is attributable to the external cell participants. |
|
(3) |
Foreign currency exchange rate gains (losses) relate to the impact of foreign exchange rate movements on foreign currency denominated loss reserves predominately associated with premium assumed from an international medical professional liability insured in our Specialty P&C segment. Our participation in this program has grown in recent years which has led to greater volatility in our results of operations even with nominal movements in exchange rates given the size of the reserve. We mitigate foreign exchange rate exposure on our Consolidated Balance Sheet by generally matching the currency and duration of associated investments to the corresponding loss reserves. In accordance with GAAP, the impact on the market value of available-for-sale fixed maturities due to changes in foreign currency exchange rates is reflected as a part of OCI. Conversely, the impact of changes in foreign currency exchange rates on loss reserves is reflected through net income (loss) as a component of other income. Therefore, we believe foreign currency exchange rate gains (losses) in our Consolidated Statements of Income and Comprehensive Income in isolation are not indicative of our operating performance. |
|
(4) |
The 21% rate is the annual expected statutory tax rate associated with the taxable or tax deductible items listed above. We utilized the estimated annual effective tax rate method for the three months ended |
Non-GAAP Operating ROE
The following table is a reconciliation of ROE to Non-GAAP operating ROE for the three months ended
|
|
Three Months Ended
|
||||
|
|
2024 |
|
2023 |
||
|
ROE(1) |
1.7 |
% |
|
(2.5 |
%) |
|
Pre-tax effect of items excluded in the calculation of Non-GAAP operating ROE |
(0.2 |
%) |
|
(0.1 |
%) |
|
Tax effect, at 21%(2) |
— |
% |
|
— |
% |
|
Non-GAAP operating ROE |
1.5 |
% |
|
(2.6 |
%) |
|
(1) |
Quarterly amounts are annualized. Refer to our |
|
(2) |
The 21% rate is the statutory tax rate associated with the taxable or tax deductible items. See further discussion in footnote 4 in this section under the heading "Non-GAAP Operating Income." |
Non-GAAP Adjusted Book Value per Share
The following table is a reconciliation of our book value per share to Non-GAAP adjusted book value per share at
|
|
Book Value Per Share |
||
|
Book Value Per Share at |
$ |
21.82 |
|
|
Less: AOCI Per Share(1) |
|
(4.01 |
) |
|
Non-GAAP Adjusted Book Value Per Share at |
|
25.83 |
|
|
Increase (decrease) to Non-GAAP Adjusted Book Value Per Share during the three months ended |
|
||
|
Net income (loss) |
|
0.09 |
|
|
Other(2) |
|
(0.04 |
) |
|
Non-GAAP Adjusted Book Value Per Share at |
|
25.88 |
|
|
Add: AOCI Per Share(1) |
|
(4.06 |
) |
|
Book Value Per Share at |
$ |
21.82 |
|
|
(1) |
Primarily the impact of accumulated unrealized investment gains (losses) on our available-for-sale fixed maturity investments. See Note 9 of the Notes to Condensed Consolidated Financial Statements in our |
|
(2) |
Includes the impact of share-based compensation. |
Conference Call Information
Callers who wish to avoid operator wait times and receive unique call access details may preregister using this link: https://www.netroadshow.com/events/login?show=77ece0eb&confild=63389.
The conference call will also be webcast at https://events.q4inc.com/attendee/483256153.
A replay will be available by telephone for at least 7 days after the call date. US-based investors may access the replay by dialing (866) 813-9403 (toll free) or (929) 458-6194, and international investors may dial +44 (204) 525-0658. The access code for all attendees is 547985. A replay will also be available for at least one year at investor.proassurance.com. Investors may follow @ProAssurance on X (formerly Twitter) to be notified of the latest news about
About
Caution Regarding Forward-Looking Statements
Any statements in this news release that are not historical facts or explicitly stated as an opinion are specifically identified as forward-looking statements. These statements are based upon our estimates and anticipation of future events and are subject to significant risks, assumptions and uncertainties that could cause actual results to differ materially from the expected results described in the forward-looking statements. Forward-looking statements are identified by words such as, but not limited to, “anticipate,” “believe,” “estimate,” “expect,” “hope,” “hopeful,” “intend,” “likely,” “may,” “optimistic,” “possible,” “potential,” “preliminary,” “project,” “should,” “will,” and other analogous expressions.
Although it is not possible to identify all of these risks and factors, they include, among others, the following: inadequate loss reserves to cover the Company's actual losses; inherent uncertainty of models resulting in actual losses that are materially different than the Company's estimates; adverse economic factors; a decline in the Company's financial strength rating; loss of one or more key executives; loss of a group of agents or brokers that generate significant portions of the Company's business; failure of any of the loss limitations or exclusions the Company employs, or change in other claims or coverage issues; adverse performance of the Company's investment portfolio; adverse market conditions that affect its excess and surplus lines insurance operations; and other risks described in the Company's filings with the
src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20240506179693r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />
View source version on businesswire.com: https://www.businesswire.com/news/home/20240506179693/en/
SVP, Investor Relations
800-282-6242 • 205-776-3028 • [email protected]
Source:
Fundamental Global Inc. Announces Acquisition of Strong/MDI Screen Systems, Inc. by FG Acquisition Corp. at a $30 Million Valuation
Higginbotham and Barnard Insurance Group Form Powerful North Texas Team
Advisor News
- Survey finds some support for DOL fiduciary rule
- Nonprofit involvement: How do you get business and WIIFM?
- Workers still concerned about financial well-being
- Transferring generational wealth involves more than financial assets
- Most preretirees believe they’ll need a bigger income in retirement
More Advisor NewsAnnuity News
- Equitable hones in on annuity delivery across channels after strong Q3
- Maintaining annuity sales momentum with Gen X
- Best’s Special Report: Smaller Companies Face Cash Flow Crunch from Uptick in U.S. Life/Annuity Surrenders
- Jackson Increases Access to RILA Product through Distribution Partnership with JPMorganChase
- Survey finds some support for DOL fiduciary rule
More Annuity NewsHealth/Employee Benefits News
- Election Day 2024 live results: Advisory question on expanding reproductive health coverage in Illinois
- HealthPartners, UnitedHealthcare reach deal on senior Medicare Advantage coverage
- Fact Sheet (q3 2024 fact sheet)
- Molina Healthcare of Texas Supports Walk to End Alzheimer's in Dallas
- New Findings from University of Arkansas for Medical Sciences Describe Advances in Cancer (Retirement Behavior of Cancer Survivors: Role of Health Insurance): Cancer
More Health/Employee Benefits NewsLife Insurance News
- LINCOLN NATIONAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lincoln National Corporation – LNC
- Supplementary financial information (pa e q324 finsupp)
- Earnings news release (pa e q324 earnings)
- Jackson Increases Access to RILA Product through Distribution Partnership with JPMorganChase
- 2024 Supplemental Report Q3 Quarterly Statement
More Life Insurance News